Statement of Cash FlowsIndirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$292,970		$275,040
Accounts receivable (net)		106,130		98,780
Inventories		299,610		292,480
Investments		0		113,310
Land		153,670		0
Equipment		330,560		258,580
Accumulated depreciationequipment		(77,390)		(69,730)
	Total assets	$1,105,550		$968,460
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$200,100		$190,790
Accrued expenses payable (operating expenses)		19,900		25,180
Dividends payable		11,060		8,720
Common stock, $10 par		59,700		47,450
Paid-in capital: Excess of issue price over par-common stock		224,430		131,710
Retained earnings		590,360		564,610
	Total liabilities and stockholders equity	$1,105,550		$968,460

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

The investments were sold for $132,570 cash.

Equipment and land were acquired for cash.

There were no disposals of equipment during the year.

The common stock was issued for cash.

There was a $71,270 credit to Retained Earnings for net income.

There was a $45,520 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
Net income	$
Adjustments to reconcile net income to net cash flow from operating activities:
Changes in current operating assets and liabilities:
Net cash flow from operating activities		$
Cash flows from investing activities:
	$
Net cash flow used for investing activities
Cash flows from financing activities:
	$
Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$